For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

When the U.S. Congress passed the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act in August 1990, it honored a young man who had acquired HIV from a blood transfusion five years earlier ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

In a multicohort analysis of patients with HIV, those with mental health disorders had a markedly higher risk for mortality than those without such conditions, leading to a shorter lifespan. The ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...

For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug that offers 100% protection with its twice-yearly injections. It's a landmark ...

July 25 (Reuters) - The European Union's drugs regulator has recommended approval of Gilead Sciences' (GILD.O), opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...